For Healthcare Professionals

It’s never been so easy to connect your patients with world-class research.

TrialNet offers a unique screening test for relatives of people with T1D that can detect the disease at its earliest stage. We look for autoantibodies that signal an increased risk of T1D years before symptoms appear.

The JDRF, ADA and Endocrine Society now classify having two or more of these autoantibodies as early stage T1D. Research shows that almost all individuals who have two or more of these autoantibodies will develop T1D.

Those at increased risk may be eligible to take part in clinical studies to change the course of the disease. There’s no cost to you or your patients.

Here’s how you can help

Inform your patients about the availability and importance of risk screening—now listed as a standard of care by the American Diabetes Association (2017 ADA Standards of Medical Care in Diabetes). Contact to order patient resources or contact us at 800-425-8361.

Arrange for a screening event. Just select the location and date. We’ll assist you with logistics and promotion, provide screening test kits, cover any associated costs, and even provide a phlebotomist, if needed.